Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H22N2O |
| Molecular Weight | 294.3908 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCCN1C2=CC=CC=C2CC(=O)C3=CC=CC=C13
InChI
InChIKey=PXHIRIWYXDUSMR-UHFFFAOYSA-N
InChI=1S/C19H22N2O/c1-20(2)12-7-13-21-17-10-5-3-8-15(17)14-19(22)16-9-4-6-11-18(16)21/h3-6,8-11H,7,12-14H2,1-2H3
| Molecular Formula | C19H22N2O |
| Molecular Weight | 294.3908 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/5459338
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5459338
KETIPRAMINE, an imipramine derivative, is a tricyclic antidepressant. In clinical trials, it was found to be as effective as imipramine for the depression treatment, with fewer secondary effects.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A highly enantioselective organocatalytic method for reduction of aromatic N-alkyl ketimines. | 2008 |
|
| Highly efficient and enantioselective cyclization of aromatic imines via directed C-H bond activation. | 2004-06-16 |
|
| Ketipramine fumarate as compared to imipramine in depressed outpatients. | 1971-05 |
|
| Open trial evaluation of keto-imipramine. | 1971-01 |
|
| Ketipramine in the therapy of depression in outpatients. | 1970-07-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:28:18 GMT 2025
by
admin
on
Wed Apr 02 08:28:18 GMT 2025
|
| Record UNII |
U5C4H63K5U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U5C4H63K5U
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
SUB08369MIG
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
796-29-2
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
100000082869
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
2249
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
Ketipramine
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
DTXSID60229790
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
C83856
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
28424
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110856
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY | |||
|
C027682
Created by
admin on Wed Apr 02 08:28:18 GMT 2025 , Edited by admin on Wed Apr 02 08:28:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |